# TMPRSS11D

## Overview
TMPRSS11D is a gene that encodes the protein transmembrane serine protease 11D, a type II transmembrane serine protease (TTSP) involved in various physiological processes. This protease is characterized by its distinct domain organization, including a transmembrane domain and a serine protease domain, which are crucial for its enzymatic activity (Fraser2024Structural; Escalante2021Structural). TMPRSS11D is primarily expressed in epithelial tissues, particularly in the human airways, where it plays a significant role in maintaining epithelial barrier function and facilitating cellular communication (Fraser2024Structural). The protein is involved in the activation of protease zymogens and the processing of cellular substrates, which are essential for tissue remodeling and immune responses (Escalante2021Structural). Additionally, TMPRSS11D has been implicated in the pathogenesis of viral infections, such as those caused by SARS-CoV-2, by facilitating viral entry into host cells (Kishimoto2021TMPRSS11D). Its clinical significance extends to its potential role in cancer progression and respiratory diseases, making it a target for therapeutic interventions (Duhaime2016Cell; Menou2017Human).

## Structure
TMPRSS11D is a type II transmembrane serine protease (TTSP) characterized by a distinct domain organization. It includes a small cytoplasmic domain, a transmembrane domain, a SEA domain, and a C-terminal serine protease domain (Fraser2024Structural). The primary structure of TMPRSS11D features a catalytic triad composed of histidine, aspartic acid, and serine, which is conserved across the TMPRSS family (Escalante2021Structural).

The secondary structure of TMPRSS11D includes unique features in its substrate binding cleft. The S1 subsite is formed by D362 and Q392, which interact with P1 Arg residues, while the S1' subsite contains a unique H211 residue (Fraser2024Structural). The tertiary structure is characterized by the presence of disulfide-linked zymogen activation motifs, which are crucial for its autocleavage activation (Fraser2024Structural).

TMPRSS11D's quaternary structure involves interactions with other molecules, as evidenced by its ability to form complexes with inhibitors like nafamostat, although these interactions are rapidly reversible (Fraser2024Structural). The protein undergoes post-translational modifications, such as glycosylation, which may influence its stability and function (Fraser2024Structural).

## Function
TMPRSS11D is a type II transmembrane serine protease (TTSP) that plays a role in various molecular processes within epithelial tissues. It is involved in the cleavage of peptide bonds, which is crucial for the activation of protease zymogens and the processing of cellular substrates, including membrane proteins and extracellular matrix components (Fraser2024Structural; Escalante2021Structural). TMPRSS11D is expressed in the human airways and is implicated in maintaining epithelial barrier function and facilitating cellular communication (Fraser2024Structural).

The protease activity of TMPRSS11D is regulated through zymogen activation, a process that involves autocleavage of its own activation motifs, allowing it to exert its enzymatic functions at the cell surface (Fraser2024Structural). This activation is essential for its role in proteolytic cascades, which are important for tissue remodeling and immune responses (Escalante2021Structural).

TMPRSS11D's substrate specificity is influenced by unique structural features in its substrate binding sites, which may affect its interaction with inhibitors and substrates (Fraser2024Structural). These structural characteristics make TMPRSS11D a potential target for therapeutic interventions, particularly in the context of viral infections (Fraser2024Structural).

## Clinical Significance
TMPRSS11D, a gene encoding the human airway trypsin-like protease (HAT), is implicated in various diseases due to alterations in its expression. In squamous cell carcinogenesis, particularly in the cervix and esophagus, there is a notable loss of HAT expression as the carcinoma progresses from Grade I to Grade III. This decrease in expression is associated with the dedifferentiation of epithelial cells, a hallmark of squamous cell carcinoma, suggesting that TMPRSS11D could serve as a marker for clinical grading and prognosis in these cancers (Duhaime2016Cell).

In cervical cancer, TMPRSS11D expression is significantly upregulated in cancerous tissues compared to normal tissues. Knockdown studies in cervical cancer cell lines have shown that reducing TMPRSS11D expression suppresses cell proliferation, migration, and invasion, and affects the epithelial-mesenchymal transition (EMT), indicating its role in tumor progression and metastasis (Yan2019Retracted).

TMPRSS11D is also associated with respiratory diseases. Its expression in the respiratory tract is linked to inflammatory responses and tissue remodeling, potentially influencing conditions like chronic obstructive pulmonary disease (COPD) (Kucher2021Genetic; Menou2017Human).

## Interactions
TMPRSS11D, a type II transmembrane serine protease, is involved in the activation of viral spike proteins, facilitating viral entry into host cells. It interacts with the SARS-CoV-2 spike protein, enhancing the virus's ability to enter and replicate within host cells, such as those expressing human angiotensin-converting enzyme 2 (ACE2) (Kishimoto2021TMPRSS11D). TMPRSS11D also plays a role in the formation of large syncytia, which are multinucleated cells resulting from the fusion of infected cells, indicating its involvement in cell-to-cell fusion processes (Kishimoto2021TMPRSS11D).

TMPRSS11D interacts with nafamostat, a serine protease inhibitor, which acylates the conserved catalytic serine residue of TMPRSS11D, temporarily blocking its enzymatic activity. However, this inhibition is short-lived due to the rapid hydrolysis of the acyl-enzyme complex (Fraser2024Structural). The structural analysis of TMPRSS11D reveals unique features in its substrate binding cleft, which could be targeted for therapeutic purposes (Fraser2024Structural). TMPRSS11D's interactions with viral proteins and inhibitors highlight its potential as a target for antiviral drug development, particularly in the context of respiratory viral infections (Fraser2024Structural).


## References


[1. (Menou2017Human) Awen Menou, JanWillem Duitman, Pauline Flajolet, Jean-Michel Sallenave, Arnaud André Mailleux, and Bruno Crestani. Human airway trypsin-like protease, a serine protease involved in respiratory diseases. American Journal of Physiology-Lung Cellular and Molecular Physiology, 312(5):L657–L668, May 2017. URL: http://dx.doi.org/10.1152/ajplung.00509.2016, doi:10.1152/ajplung.00509.2016. This article has 32 citations.](https://doi.org/10.1152/ajplung.00509.2016)

[2. (Kishimoto2021TMPRSS11D) Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, Yasuko Orba, Hirofumi Sawa, and Michihito Sasaki. Tmprss11d and tmprss13 activate the sars-cov-2 spike protein. Viruses, 13(3):384, February 2021. URL: http://dx.doi.org/10.3390/v13030384, doi:10.3390/v13030384. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/v13030384)

[3. (Kucher2021Genetic) A. N. Kucher, N. P. Babushkina, A. A. Sleptcov, and M. S. Nazarenko. Genetic control of human infection with sars-cov-2. Russian Journal of Genetics, 57(6):627–641, June 2021. URL: http://dx.doi.org/10.1134/S1022795421050057, doi:10.1134/s1022795421050057. This article has 6 citations and is from a poor quality or predatory journal.](https://doi.org/10.1134/S1022795421050057)

4. (Fraser2024Structural) Structural basis of TMPRSS11D specificity and autocleavage activation. This article has 0 citations.

[5. (Yan2019Retracted) Kun Yan, Chunyan Hu, Chen Liu, Guanghua Chu, Xinru Wang, Shuyun Ma, and Long Li. Retracted article: knockdown of tmprss11d inhibits the proliferation, migration and invasion of cervical cancer cells. RSC Advances, 9(37):21591–21600, 2019. URL: http://dx.doi.org/10.1039/c9ra02482d, doi:10.1039/c9ra02482d. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/c9ra02482d)

[6. (Duhaime2016Cell) Michael J. Duhaime, Khaliph O. Page, Fausto A. Varela, Andrew S. Murray, Michael E. Silverman, Gina L. Zoratti, and Karin List. Cell surface human airway trypsin-like protease is lost during squamous cell carcinogenesis: cell surface human airway trypsin-like protease. Journal of Cellular Physiology, 231(7):1476–1483, February 2016. URL: http://dx.doi.org/10.1002/jcp.25173, doi:10.1002/jcp.25173. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.25173)

7. (Escalante2021Structural) Structural Modeling of the TMPRSS Subfamily of Host Cell Proteases Reveals Potential Binding Sites. This article has 0 citations.